Select for export Single dose of psilocybin improves depressive symptoms in Phase 2 study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31093 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2023-10-29 Authors unavailable OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-023-06474-9 PubMed 37855864 Copy citation Copy BibTeX Psychopharmacology 2023-10-18 Arya Rahbarnia, Zhaoxia Li, Paul Fletcher OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231205692 PubMed 37842884 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-10-15 Natalia Malikowska-Racia, Maciej Koniewski, Joanna Gołębiowska, Piotr Popik OpenAlex Published psilocybin AnxietyChronic PainPharmacology Animal Study More
Select for export Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-44153-z PubMed 37838755 Copy citation Copy BibTeX Scientific Reports 2023-10-13 Nathalie M. Rieser, Ladina P Gubser, Flora Moujaes, Patricia Duerler, Candace R. Lewis, Lars Michels OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Other More
Select for export Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/dep.2023.21 Copy citation Copy BibTeX Research Directions Depression 2023-10-12 Ian B. Hickie, Allan H. Young, F. Markus Leweke OpenAlex Published psilocybin DepressionPharmacologyTreatment-Resistant Depression Other More
Select for export Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future Abstract available at the source but not redistributed here. Read at source. Details DOI 10.48091/gsr.v3i2.62 Copy citation Copy BibTeX Georgetown Scientific Research Journal 2023-10-09 Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter OpenAlex Published psilocybin DepressionNeuroplasticityPharmacology Other More
Select for export Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2023.2268640 PubMed 37815125 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2023-10-09 Kiffer G. Card, Ashmita Grewal, Kalysha Closson, Gina Martin, Laura Baracaldo, Sandra Allison OpenAlex Published psilocybin PharmacologyObservational StudySafety Observational Study More
Select for export Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2023.10.06.561183 Copy citation Copy BibTeX bioRxiv 2023-10-06 Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R bioRxiv PREPRINT (not peer reviewed) psilocybinpsilocin DepressionAddictionBrain Imaging Systematic Review More
Select for export Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.3050 PubMed 37795632 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2023-10-04 Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40814-023-01399-8 PubMed 37798662 Copy citation Copy BibTeX Pilot and Feasibility Studies 2023-10-04 C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Randomized Controlled Trial More
Select for export Psilocybin shows promising results in subjects continuing to use an antidepressant Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31089 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2023-10-03 Authors unavailable OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODEL No abstract availability was recorded for this entry. Details DOI 10.1016/j.ibneur.2023.08.1097 Copy citation Copy BibTeX IBRO Neuroscience Reports 2023-09-30 Ines Erkizia-Santamaría, J. Javier Meana, Igor Horrillo, Jorge E. Ortega OpenAlex Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Other More
Select for export Neuroimaging in psychedelic drug development: past, present, and future. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-023-02271-0 PubMed 37759038 Copy citation Copy BibTeX Unknown journal 2023-09-26 Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. Europe PMC Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export Psilocybin kann offenbar Depressionen lindern No abstract availability was recorded for this entry. Details DOI 10.1007/s15006-023-3025-6 PubMed 37758991 Copy citation Copy BibTeX MMW - Fortschritte der Medizin 2023-09-26 Thomas Müller OpenAlex Published psilocybin DepressionPharmacology Other More
Select for export Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala No abstract availability was recorded for this entry. Details DOI 10.1038/s41386-023-01744-8 PubMed 37752222 Copy citation Copy BibTeX Neuropsychopharmacology 2023-09-25 Thomas J. Kelly, Emma M. Bonniwell, Lianwei Mu, Xiaojie Liu, Ying Hu, Vladislav Friedman OpenAlex Published psilocybin NeuroplasticityPharmacologyReceptor Pharmacology Other More
Select for export The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsptsci.3c00137 PubMed 37854624 Copy citation Copy BibTeX ACS Pharmacology & Translational Science 2023-09-17 Richa Tyagi, Tanishka S. Saraf, Clinton E. Canal OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-09-12 Lobe Sciences Ltd. ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin AddictionPharmacologyClinical Trial Clinical Trial More
Select for export Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.45169 PubMed 37842360 Copy citation Copy BibTeX Cureus 2023-09-12 NM Mahmudul Alam Bhuiya, Robin J. Jacobs, Karina Wang, Yiqun Sun, Brenda Nava, Luke Sampiere OpenAlex Published psilocybin DepressionAnxietyOCD Review Article More
Select for export A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jbc.2023.105231 PubMed 37690691 Copy citation Copy BibTeX Journal of Biological Chemistry 2023-09-08 Chen Xue, Jing Li, Lisa Yu, Francesca Maule, Li-Mei Chang, Jonathan Gallant OpenAlex Published psilocybin PharmacologyReceptor PharmacologyEpigenetics Other More
Select for export Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.ajp-rj.2023.190103 Copy citation Copy BibTeX American Journal of Psychiatry Residents Journal 2023-09-07 Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Clinical Trial More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.